`571-272-7822
`
`Paper 64
`Date: June 18, 2024
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`MYLAN PHARMACEUTICALS INC., DR. REDDY’S
`LABORATORIES, INC., DR. REDDY’S LABORATORIES, LTD., SUN
`PHARMACEUTICAL INDUSTRIES LTD., AND SUN
`PHARMACEUTICAL INDUSTRIES, INC.,
`Petitioner,
`v.
`NOVO NORDISK A/S,
`Patent Owner.
`____________
`
`IPR2023-007241
`Patent 10,335,462 B2
`____________
`
`
`
`REVISED SCHEDULING ORDER
`
`
`
`
`
`
`
`1 IPR2024-00009 (Dr. Reddy’s Laboratories) and IPR2024-00107 (Sun
`Pharmaceutical Industries) have been joined with this proceeding.
`
`
`
`IPR2023-00724
`Patent 10,335,462 B2
`
`Novo Nordisk, A/S, requested a conference call to discuss a one-
`month extension of all due dates, including the oral hearing date, to
`accommodate the scheduling of depositions of Petitioner’s six declarants
`that filed declarations in support of Petitioner’s Reply. See Ex. 3004.
`Petitioner did not take a position on Patent Owner’s request. Id.
`
`A conference call was held on June 6, 2024, to discuss the proposed
`changes to the schedule for this proceeding. During the conference, we
`authorized the parties to file a joint stipulation concerning the proposed due
`dates for Due Dates 3 through 7, but took under advisement the change in
`the oral hearing due date to confirm availability for an oral hearing during
`the week of August 26, 2024. Counsel confirmed that each would be
`available for an oral hearing during that week.
`
`On June 7, 2024, the parties filed a joint stipulation to modify Due
`Dates 3 through 7 as follows (omitting events related to a motion to amend
`that Patent Owner has agreed not to file in this proceeding). See Paper 56, 1,
`1 n.1 (“Joint Stipulation”).
`
`Due Date
`DUE DATE 3: Patent Owner’s
`sur-reply to reply
`DUE DATE 4: Request for oral
`argument
`DUE DATE 5: Motion to
`exclude evidence
`DUE DATE 6: Opposition to
`motion to exclude and Request
`for prehearing conference
`DUE DATE 7: Reply to
`opposition to motion to exclude
`DUE DATE 8: Oral argument
`
`Current Date
`July 3, 2024
`
`Proposed Due Date
`August 5, 2024
`
`June 12, 2024
`
`July 12, 2024
`
`July 8, 2024
`
`August 8, 2024
`
`July 15, 2024
`
`August 15, 2024
`
`July 18, 2024
`
`July 30, 2024
`
`August 19, 2024
`To be specified by
`the Board
`
`2
`
`
`
`IPR2023-00724
`Patent 10,335,462 B2
`We have since confirmed the morning of Tuesday, August 27, 2024,
`as the date and time for oral argument should it be requested by the parties.
`We have confirmed that a requested in-person hearing will be held at the
`USPTO headquarters in Alexandria in our largest courtroom, Hearing
`Room A.
`
`ORDER
`
`Accordingly, it is
`ORDERED that DUE DATE 8 for Oral Argument is set for the
`morning of Tuesday, August 27, 2024;
`FURTHER ORDERED that the the due dates set forth in the Joint
`Stipulation by the parties filed for Due Dates 3 through 7 filed on June 7,
`2024, remain in effect.
`
`3
`
`
`
`IPR2023-00724
`Patent 10,335,462 B2
`For PETITIONER:
`
`Brandon M. White
`Emily J. Greb
`Courtney Prochnow
`Christopher D. Jones
`Jonathan I. Tietz
`Matthew A. Lembo
`PERKINS COIE LLP
`white-ptab@perkinscoie.com
`greb-ptab@perkinscoie.com
`prochnow-ptab@perkinscoie.com
`jones-ptab@perkinscoie.com
`tietz-ptab@perkinscoie.com
`lembo-ptab@perkinscoie.com
`Semaglutide-Ozempic@perkinscoie.com
`
`For PATENT OWNER:
`
`J. Steven Baughman
`Megan Raymond
`GROOMBRIDGE, WU, BAUGHMAN & STONE LLP
`steve.baughman@groombridgewu.com
`megan.raymond@groombridgewu.com
`
`
`4
`
`